Perioperative Surgical Home. Jessica Hoge, M.D. Co-Director Bozeman Health POSH; Hospitalist
|
|
- Paulina Goodwin
- 5 years ago
- Views:
Transcription
1 Perioperative Surgical Home Jessica Hoge, M.D. Co-Director Bozeman Health POSH; Hospitalist
2 Disclosures Prior Medical Director of the Bozeman Health Research Group
3 What is a Perioperative Surgical Home? Patient-centered Reduced length of stay Coordinated care Reduced readmissions Standardization Reduced complications Empowered patients Reduced costs Preoperative Intraoperative Postoperative Post Discharge A patient-centered and physician-led multidisciplinary team-based system of coordinated care that guides the patient throughout the entire surgical experience. - Marc Warner, MD Mayo Clinic College of Medicine
4 What is a Perioperative Surgical Home? Hospitalists / Anesthesiologists Discharge planning Orthopedic surgeons Physical Therapy Pharmacy Nutritionists Educators Respiratory Therapy Preoperative Intraoperative Postoperative Post Discharge A patient-centered and physician-led multidisciplinary team-based system of coordinated care that guides the patient throughout the entire surgical experience. - Marc Warner, MD Mayo Clinic College of Medicine
5 Preoperative standardization Labs/ diagnostics SNF risk identification Cardiac risk stratification Patient education OSA screening Medications Frailty assessment Identify opiate track Preoperative Postoperative
6 Risk assessment & prediction tool RAPT score Predicts discharge disposition after total joint replacement 90% <6 & >9
7 Intraoperative standardization Normothermia Total joints: TXA Goal-directed IVF Total joints: Avoid foley Total joints: Neuraxial Multimodal analgesia GA: 80% FIO2 Intensive BG control Preoperative Intraoperative
8 Multimodal Pain for Total Knee Pre: Tylenol, Celebrex, Gabapentin, oxycodone Bupivacaine spinal Versed Propofol Fentanyl Ketamine Adductor canal catheter Preoperative Intraoperative
9 Postoperative standardization PONV treatment DVT prophylaxis Bowel regimen Early ambulation Opiate track Avoid post-operative IVF Total knee: Adductor block Colorectal: eat regular diet POD #0 Preoperative Intraoperative Postoperative
10 Post-Discharge standardization Discharge plan already identified preoperatively Patient has realistic expectations for recovery time Patient has realistic expectations for pain Patient access for post-operative issues Communication with PCP, ER Preoperative Intraoperative Postoperative Post Discharge
11 Q&A #1 75-yo male NSTEMI 3 months ago 1 DES RCA. Preserved EF Discharged on aspirin, clopidogrel, atorvastatin, and metoprolol. Referred to you prior to a total knee arthroplasty for severe OA Which of the following preoperative recommendations would you make to this patient? No recurrent angina sx
12 Q&A #1 1. Defer surgery for 1 year post-pci 2. Stop aspirin 7 days prior to surgery 3. Stop clopidogrel 7 days prior to surgery 4. Stop both aspirin and clopidogrel 7 days prior to surgery
13 Q&A #1 1. Defer surgery for 1 year post-pci 2. Stop aspirin 7 days prior to surgery 3. Stop clopidogrel 7 days prior to surgery 4. Stop both aspirin and clopidogrel 7 days prior to surgery
14 Q&A #1 This is elective surgery! Defer for 1 year. For patients who cannot wait one year, defer for minimum of 6 months for DES Cessation of DAPT prematurely is the strongest predictor of stent thrombosis PCI to surgery had increased MACE if within 1 year (OR 2.59, 95% CI ). Case control N=24313 NCS with 1120 stented Mahmoud KD, et al. J Am Coll Cardiol 2016;67(9):
15 Cardiac disease Screen for active angina. N= 1568 NSQIP Previous MI & NCS. Primary outcome MI/cardiac arrest (5.8%). Angina is an independent predictor for postop MI. OR 2.49 [CI ]. Pandey A et al. Am J Cardiol (8):
16 Cardiac disease Risk stratify using RCRI or NSQIP; Gupta If high risk (>1%), only perform cardiac stress testing for elective surgery if cardiac symptoms or METS< ACC/AHA Guidelines
17 Cardiac disease If 30-day post-op mortality was a disease, it would be the 3 rd leading cause of death. Daniel Sessler, Cleveland Clinic Threshold for injury is intraoperative MAP < 65 mmhg. Injury worse with the longer and deeper hypotension. Masha, et al. Anesthesiology; 2015;123:79-91.
18 Q&A #2 60-yo female h/o atrial fibrillation and embolic stroke with no residual deficits She takes apixaban bid and metoprolol daily. Orthopedics recommends right hip She is referred to you from his orthopedic surgeon for preoperative assessment prior to elective right hip arthroplasty. Which of the following preoperative recommendations would you make to this patient? replacement for her severe OA Anesthesiology plans on performing neuraxial anesthesia for the surgery.
19 Q&A #2 1. Stop apixaban 3 days prior to surgery and continue metoprolol. Restart apixaban postop if hemostasis is achieved. 2. Stop apixaban 3 days prior to surgery and continue metoprolol. Restart apixaban the day of surgery if hemostasis is achieved. 3. Stop apixaban 3 days prior to surgery and continue metoprolol. Start enoaxparin bridge before and after surgery. Restart apixaban the day of surgery if hemostasis is achieved. 4. Stop apixaban 3 days prior to surgery and continue metoprolol. Start enoaxparin bridge before and after surgery. Restart apixaban post-op if hemostasis is achieved.
20 Q&A #2 1. Stop apixaban 3 days prior to surgery and continue metoprolol. Restart apixaban postop if hemostasis is achieved. 2. Stop apixaban 3 days prior to surgery and continue metoprolol. Restart apixaban the day of surgery if hemostasis is achieved. 3. Stop apixaban 3 days prior to surgery and continue metoprolol. Start enoaxparin bridge before and after surgery. Restart apixaban the day of surgery if hemostasis is achieved. 4. Stop apixaban 3 days prior to surgery and continue metoprolol. Start enoaxparin bridge before and after surgery. Restart apixaban post-op if hemostasis is achieved.
21 Q&A #2 Avoid bridging except for HIGH thrombotic risk which outweighs bleeding risk. This patient s CHA2DS2-VASc = 3. (High thrombotic risk is 7) When to stop NOAC: AHA and SHM recommend discontinuation based on CrCl. For apixaban, 48 hr if intermed/high bleed risk, but ASRA has stricter guidelines (3 days). When in doubt, call the anesthesiologist. When to restart NOAC: h after major surgery if hemostasis achieved. When in doubt, check with surgery. ASRA allows resuming within 6 hr. Doherty JU, et al ACC consensus periprocedural anticoagulation nonvalvular Afib. Horlocker TT, et al. ASRA guidelines. Reg Anesth Pain Med. 2010;35(1):64. with 2016 update Johnson SA, Labrin J. Periprocedural Bridging Anticoagulation. JHM; Published online January 24, Raval, et al. AHA Scientific Statement: NOAC in the acute care and periprocedural setting. Circulation: 2017;
22 Johnson SA, Labrin J. Periprocedural Bridging Anticoagulation. JHM; Published online January 24, 2018.
23
24 Obstructive Sleep Apnea OSA & sedation / anesthesia associated with higher complications (respiratory complications, postoperative cardiac events and transfer to the ICU) 17% fewer major complications if neuraxial anesthesia used instead of general anesthesia in OSA pts for total joint replacement Kaw et al, Br J Anaesth 2012;109(6): Memtosoudis et al. Anesth Pain Med 2013;38(4): Nagappa et al. PloS 2015
25
26 Q&A #3 1. High muscle / High fat Which of the following body phenotypes 2. Low muscle / Low fat have the highest 1-year mortality rate following elective surgery? 3. Low muscle / High fat 4. High muscle / Low fat
27 1. High Muscle / High Fat 2. Low Muscle / Low Fat 3. Low Muscle / High Fat 4. High Muscle / Low Fat
28 ~14% 1-year post-op mortality 1. High Muscle / High Fat 2. Low Muscle / Low Fat 3. Low Muscle / High Fat 4. High Muscle / Low Fat
29 Frailty N=202,911 (6289; 3.1% were frail) Retrospective cohort for elective NCS Increased risk for death in frail patients existed between different surgery types, but was strongest after total joint arthroplasty. (HR, 3.79; 95% CI, for hip replacement; HR, 2.68; 95% CI, for knee replacement) McIsaac DI, Bryson GL, van Walraven C. JAMA Surg. 2016;15(6):
30 Frailty Measuring frailty Nutrition Medication management Discharge planning Opiate naïve track Prehabilitation? Delirium risk
31 Frailty Timed Up and Go test (TUG) Easy and quantifiable Cutoff of 10 would identify 93% frail, but specificity only 62% Afilalo J, et al. JACC. 2014;63(8): Savva GM et al. 2012;68(4):441-6.
32 Prehabilitation Enhancement of the preoperative condition of the patient Aims to improve the functional capacity of the patient before surgery with the intent to minimize morbidity and improve surgical recovery.
33 Q&A #4 43-yo female Rheumatoid arthritis Which of the following preoperative recommendations would you make to this patient? Infliximab IV Q4 weeks for a year. She is a marathon runner and has no other medical problems. No active infections or RA flares. She was offered elective right total knee replacement for severe right knee pain.
34 Q&A #4 1. Continue infliximab and schedule surgery after monthly dose 2. Continue infliximab and schedule surgery the week prior to monthly dose 3. Stop infliximab and schedule surgery on week 5 relative to last dose 4. Stop infliximab and schedule surgery on week 9 relative to last dose
35 Q&A #4 1. Continue infliximab and schedule surgery after monthly dose 2. Continue infliximab and schedule surgery the week prior to monthly dose 3. Stop infliximab and schedule surgery on week 5 relative to last dose 4. Stop infliximab and schedule surgery on week 9 relative to last dose
36 Q&A #4 New guidelines 2017 developed by American College of Rheumatology and the American Association of Hip & Knee Surgeons for rheumatic disease patients undergoing total knee or hip surgeries. In general, continue DMARDs, hold biologics Different recommendations on immunosuppressants depending on the severity of systemic lupus erythematous Avoid stress dose steroids, taper <20 mg/day when possible Different from gastroenterologist recommendations regarding inflammatory bowel disease patients and infliximab for colorectal surgeries. Goodman, et al Arthritis Care & Research. 2017;DOI /acr.23274
37 Surgical Site Infection Prevention Total knee replacement CMS: $31K I&D for SSI: $93K non-reimbursable 2-stage exchange SSI: $187K non-reimbursable
38 Surgical Site Infection Prevention Shower within 24 hours & no shaving Chlorhexidine scrub prior (mupirocin X 5 days in addition if +MRSA) Appropriate antibiotics Blood glucose control Avoid hypothermia intraop Goal directed fluids Smoking cessation Limit steroid /biologic use* Allegranzi B, et al. WHO recommendations, Lancet 2016 *Goodman, et al Arthritis Care & Research. 2017;DOI /acr.23274
39 Surgical Site Infection Prevention HbA1C >7% increased SSI 35.3% compared to 0.0% for thoracic and lumbar spinal instrumentation surgery. Peri-operative hyperglycemia (>200 mg/dl) even without a diagnosis of diabetes is an independent risk factor for SSI at 30 days (OR 3.2, 95% CI: ). Post-operative morning hyperglycemia associated with a 3-fold increased risk of peri-prosthetic infection in lower total joints Hikata T, et al.. J Orhop Sci. 2014;19(2): Mraovic B, et al. J Diabetes Sci Technol. 2011;5(2): Richards JE, et al. J Bone Joint Surg. 2012;94(13):
40 Enhanced Recovery After Surgery ERAS Pathway for colorectal No fasting Minimally invasive surgery Avoid drains & NG tubes Early removal drains Opiate-sparing pre-op Early mobilization Goal directed IVF PO POD#0 Carmichael JC, et al. Dis Colon Rectum 2017;60: Ljungquvist O, Scott M, Fearon KC. ERAS. JAMA Surgery 2017;152(3):292-8
41 ERAS Surgical Site Prevention ERAS Pathway for colorectal Chlorhexidine shower Blood glucose control Mechanical bowel prep with oral antibiotics and IV antibiotics 1 hour prior Avoid hypothermia intraop Goal directed fluids Dedicated wound closure tray Smoking cessation Carmichael JC, et al. Dis Colon Rectum 2017;60: Ljungquvist O, Scott M, Fearon KC. ERAS. JAMA Surgery 2017;152(3):292-8
42 ERAS Pulm Complication Prevention ERAS Pathway for colorectal Ariscat pulmonary risk stratification tool (N=5099. C-stat 0.8) Inspiratory muscle training preoperatively associated with a reduction of postop atelectasis and pneumonia compared to usual care Dutta, S, et al. JHM.2016;11(3): Mazo V, et al. Anesthesiology. 2014;121: Katsura M et al Cochrane Review 2015
43 Jessica Hoge
EMERGING EVIDENCE AND BEST PRACTICES TO PREVENT SSI IN COLON PROCEDURES
EMERGING EVIDENCE AND BEST PRACTICES TO PREVENT SSI IN COLON PROCEDURES Clifford Ko, MD, MS, MSHS, FACS, FASCRS Professor of Surgery UCLA Director, ACS NSQIP, American College of Surgeons EVIDENCE Ban
More informationPreoperative Cardiac Evaluation:
Preoperative Cardiac Evaluation: The New Guidelines Hugo Quinny Cheng, MD Division of Hospital Medicine University of California, San Francisco Disclosures No financial relationships with pharmaceutical
More information2017 Bryan Health Primary Care Conference. Dale Hansen MD Bryan Heart 5/20/17
2017 Bryan Health Primary Care Conference Dale Hansen MD Bryan Heart 5/20/17 I have no financial disclosures or conflicts of interest Bridging Anticoagulation Primum Non Nocere 67 y.o. male with mechanical
More informationClinical Controversies in Perioperative Medicine
Clinical Controversies in Perioperative Medicine Hugo Quinny Cheng, MD Division of Hospital Medicine University of California, San Francisco Predicting & Managing Cardiac Risk A 70-y.o. man with progressive
More informationUpdates & Controversies in Perioperative Medicine
Updates in Perioperative Medicine Updates & Controversies in Perioperative Medicine Hugo Quinny Cheng, MD Division of Hospital Medicine University of California, San Francisco New Guidelines for Perioperative
More informationENHANCED RECOVERY PROTOCOLS FOR KNEE REPLACEMENT
ENHANCED RECOVERY PROTOCOLS FOR KNEE REPLACEMENT Jeff Gadsden, MD, FRCPC, FANZCA Associate Professor Duke University Department of Anesthesiology Regional Anesthesia and Acute Pain Medicine DISCLOSURES
More informationClinical Controversies in Perioperative Medicine
Clinical Controversies in Perioperative Medicine Hugo Quinny Cheng, MD Division of Hospital Medicine University of California, San Francisco Cardiac Evaluation: New Guidelines A 70-y.o. man with progressive
More informationCreating an Early Recovery Order Set for Colorectal Surgery-It s the Journey as well as the Destination
Creating an Early Recovery Order Set for Colorectal Surgery-It s the Journey as well as the Destination Jason D. Sciarretta, MD, FACS Grand Strand Medical Center, Myrtle Beach, SC University of South Carolina
More informationShow Me the Evidence: Epidurals, PVBs, TAP Blocks Christopher L. Wu, MD Professor of Anesthesiology The Johns Hopkins Hospital
Show Me the Evidence: Epidurals, PVBs, TAP Blocks Christopher L. Wu, MD Professor of Anesthesiology The Johns Hopkins Hospital Overview Review overall (ERAS and non-eras) data for EA, PVB, TAP Examine
More informationClick to edit Master subtitle style
Does Enhanced Recovery Improve Outcomes? Click to edit Master subtitle style Kaare Weber, MD Director of Surgery Associate Medical Director, Surgery A MEMBER OF THE MONTEFIORE HEALTH SYSTEM mes? Click
More informationAnesthetic Techniques for Rapid Recovery in Total Knee Arthroplasty
Anesthetic Techniques for Rapid Recovery in Total Knee Arthroplasty Scott T. Ball, MD Chief, Adult Joint Reconstruction Department of Orthopaedic Surgery University of California, San Diego Disclosures
More informationUpdates & Controversies in Perioperative Medicine
Updates & Controversies in Perioperative Medicine Hugo Quinny Cheng, MD Division of Hospital Medicine University of California, San Francisco Updates in Perioperative Medicine Estimating mortality in surgical
More informationEnhanced Recovery after Surgery
Enhanced Recovery after Surgery AKA ERAS What is Enhanced Recovery (ER)? Paradigm shift in surgery and surgical care of the patient Philosophy of care Perioperative continuum Multidisciplinary Patient
More informationOutpatient Total Knee Arthroplasty: Anesthetic Implications
Outpatient Total Knee Arthroplasty: Anesthetic Implications Anthony Edelman, MD, MBA Clinical Assistant Professor Director, Division of Orthopedic Anesthesia Disclosures None Objectives Examine current
More informationAsif Serajian DO FACC FSCAI
Anticoagulation and Antiplatelet update: A case based approach Asif Serajian DO FACC FSCAI No disclosures relevant to this talk Objectives 1. Discuss the indication for antiplatelet therapy for cardiac
More informationIf you reduce variability in volume administration, HOW. you can reduce post-surgical complications, LOS and associated costs 1-4
A large body of clinical evidence* demonstrates If you reduce variability in volume administration, you can reduce post-surgical complications, LOS and associated costs 1-4 Complications Too Dry Too Wet
More informationHow to Address an Inappropriately high Mortality Rate? Joe Sharma, MD Associate Professor of Surgery NSQIP Surgical Champion
How to Address an Inappropriately high Mortality Rate? Joe Sharma, MD Associate Professor of Surgery NSQIP Surgical Champion Disclosure Slide No COI and no disclosures. Hospital Mortality rate : is it
More informationPERIOPERATIVE ANESTHETIC RISK IN THE GERIATRIC PATIENT
PERIOPERATIVE ANESTHETIC RISK IN THE GERIATRIC PATIENT Susan H. Noorily, M.D. Clinical Professor of Anesthesiology Medical Director University Preoperative Medicine Center IMPORTANCE Half of all currently
More informationPostoperative Management of Patients Following Surgical Ablation
Postoperative Management of Patients Following Surgical Ablation Harold G. Roberts, Jr. Department of Cardiovascular and Thoracic Surgery West Virginia University Morgantown, WV None Disclosures Postop
More informationERAS: Enhanced Recovery After Surgery. Christopher L. Wu, M.D. Professor of Anesthesiology The Johns Hopkins University; Baltimore, Maryland
ERAS: Enhanced Recovery After Surgery Christopher L. Wu, M.D. Professor of Anesthesiology The Johns Hopkins University; Baltimore, Maryland Overview History and basic principles of ERAS Review published
More informationDisclosures. Personalized Approaches to Gastrointestinal Cancers. Objectives. What is personalized cancer care. Go through some genomic studies
Personalized Approaches to Gastrointestinal Cancers Emily Groves, MD Colorectal Surgery Assistant Professor, Division of Surgical Oncology Disclosures None Objectives What is personalized medicine and
More informationERAS. Presented by Timothy L. Beard MD, FACS, CPI Bend Memorial Clinic
ERAS Presented by Timothy L. Beard MD, FACS, CPI Bend Memorial Clinic Outline Definition Justification Ileus Pain Outline Specifics Data BMC Data Worldwide Data Implementation What is ERAS? AKA Fast-track
More informationSESSION 5 2:20 3:35 pm
SESSION 2:2 3:3 pm Strategies to Reduce Cardiac Risk for Noncardiac Surgery SPEAKER Lee A. Fleisher, MD Presenter Disclosure Information The following relationships exist related to this presentation:
More informationSenior Visceral Surgery Fast-Track in Colorectal Surgery The anesthetist s point of view
Senior Visceral Surgery Fast-Track in Colorectal Surgery The anesthetist s point of view 1st Geneva International SCIENTIFIC DAY February 3 rd 2010 E. Schiffer Dept APSI, HUG 1 Fast-Track in colorectal
More informationBaptist Health Lexington. ERAS Protocols
Baptist Health Lexington ERAS Protocols Enhanced Recovery After Surgery BHLex Colorectal ERAS Protocol Preoperative Patient/Family Education: PAT and office, ERAS brochure & educational flyer/checklist
More informationChallenges in Anticoagulation Bridging and Emerging Therapies. Disclosures and Relationships. Objectives. Dr. Cumbler has no conflicts of interest
Challenges in Anticoagulation Bridging and Emerging Therapies Ethan Cumbler MD FACP Associate Professor of Medicine Hospitalist Medicine Section University of Colorado Denver 2011 Disclosures and Relationships
More informationDisclosures. Overview. Have you ever. The Perioperative Management of Anticoagulants. No financial conflicts of interest to disclose
Disclosures No financial conflicts of interest to disclose The Perioperative Management of Anticoagulants Margaret C. Fang, MD, MPH Associate Professor of Medicine UCSF Division of Hospital Medicine Medical
More informationObjectives 9/7/2012. Optimizing Analgesia to Enhance the Recovery After Surgery CME FACULTY DISCLOSURE
Optimizing Analgesia to Enhance the Recovery After Surgery Francesco Carli, M.D.. McGill University, Montreal, QC, Canada. ASPMN, Baltimore, 2012 CME FACULTY DISCLOSURE Francesco Carli has no affiliation
More informationUpdate in Perioperative Medicine
Update in Perioperative Medicine Linda Venner MD FACP March 2018 Agenda 1 2 3 4 5 Optimized not Cleared Identify red flags for cardiac and pulmonary complications Optimize management Prevent delirium Don
More informationGuidelines PATHOLOGY: FATAL PERIOPERATIVE MI NON-PMI N = 25 PMI N = 42. Prominent Dutch Cardiovascular Researcher Fired for Scientific Misconduct
PATHOLOGY: FATAL PERIOPERATIVE MI NON-PMI N = 25 PMI N = 42 Preoperative, Intraoperative, and Postoperative Factors Associated with Perioperative Cardiac Complications in Patients Undergoing Major Noncardiac
More informationPresentation at ACS NSQIP National Conference in July Surgical Site Infection Reduction Strategies
Presentation at ACS NSQIP National Conference in July 2015 Surgical Site Infection Reduction Strategies PeaceHealth Sacred Heart Medical Center at RiverBend Level II Trauma Center 379 Beds 15,060 cases
More informationMr David A McDonald Service Improvement Manager Whole System patient Flow Improvement Programme Scottish Government
Mr David A McDonald Service Improvement Manager Whole System patient Flow Improvement Programme Scottish Government Introduction Brief update Two main topics Use of Gabapentin Local Infiltration Analgesia
More information4/27/2015. Cardiac Events #1 cause of postoperative complications/ mortality- CHF, complete heart block, MI,
Not intended for medical clearance Identify, document, and evaluate health conditions Medication Management Stratify Risks Optimize conditions within context of surgical illness Recommend measures that
More informationScope of the Problem: DAPT and Triple Therapy after Stenting
Scope of the Problem: DAPT and Triple Therapy after Stenting Kurt Huber, MD, FESC, FACC 3 rd Medical Department Cardiology & Emergency Medicine Wilhelminenhospital Vienna, Austria Session, August 30, 2010,
More informationPerioperative Management of Anticoagulation
Perioperative Management of Anticoagulation Presented By: Nibal R. Chamoun, PharmD, BCPS Clinical Assistant Professor, Clinical Coordinator Lebanese American University, School of Pharmacy Presented at:
More informationAntiplatelet and Anticoagulant management for Regional Anesthesia
Antiplatelet and Anticoagulant management for Regional Anesthesia Deborah Richman MBCHB, FFA(SA) Director of Pre-Operative Services Department of Anesthesia Stony Brook MedicineStony Brook, NY SPAQI Immediate
More informationModifiable Risk Factors in Orthopaedic Infections
Modifiable Risk Factors in Orthopaedic Infections AAOS Patient Safety Committee Burden US Surgical Site Infections (SSI) by the Numbers ~300,000 SSIs/yr (17% of all HAI; second to UTI) 2%-5% of patients
More informationChallenges in Anticoagulation and Thromboembolism
Challenges in Anticoagulation and Thromboembolism Ethan Cumbler M.D. Assistant Professor of Medicine Hospitalist Medicine Section University of Colorado Denver May 2010 No Conflicts of Interest Objectives
More informationBest Practices for Fast Track in Bariatric Surgery: Enhanced Recovery After Bariatric Surgery
Best Practices for Fast Track in Bariatric Surgery: Enhanced Recovery After Bariatric Surgery Abdelrahman Nimeri, MBBCh, FACS, FASMBS ACS NSQIP Surgeon Champion Chief of General, Thoracic & Vascular Surgery
More informationAssessing Cardiac Risk in Noncardiac Surgery. Murali Sivarajan, M.D. Professor University of Washington Seattle, Washington
Assessing Cardiac Risk in Noncardiac Surgery Murali Sivarajan, M.D. Professor University of Washington Seattle, Washington Disclosure None. I have no conflicts of interest, financial or otherwise. CME
More informationDual Antiplatelet Therapy Made Practical
Dual Antiplatelet Therapy Made Practical David Parra, Pharm.D., FCCP, BCPS Clinical Pharmacy Program Manager in Cardiology/Anticoagulation VISN 8 Pharmacy Benefits Management Clinical Associate Professor
More informationPre-operative Evaluations. Objectives. General Considerations. FP Consultation Considerations. CV Credits 7/24/2017. Brian Bachelder, MD Akron, Ohio
Pre-operative Evaluations Brian Bachelder, MD Akron, Ohio Objectives Discuss the perioperative cardiopulmonary evaluation and management of patients undergoing non-cardiac surgery Objectively estimate
More informationPreventing Surgical Site Infections: The SSI Bundle
Preventing Surgical Site Infections: The SSI Bundle 1 Why SSI? New York State 30,000 hospital discharges 1984 3.7% of patients experience serious adverse events related to medical management The top three
More informationEnhanced Perioperative Management of Older Adults
Enhanced Perioperative Management of Older Adults Bernardo Reyes, MD Assistant Professor of Geriatrics Charles E. Schmidt College of Medicine Disclosures None Interesting Facts Warhol was a sickly child,
More information8/28/2018. Pre-op Evaluation for non cardiac surgery. A quick review from 2007!! Disclosures. John Steuter, MD. None
Pre-op Evaluation for non cardiac surgery John Steuter, MD Disclosures None A quick review from 2007!! Fliesheret al, ACC/AHA 2007 Guidelines on Perioperative Cardiovascular Evaluation and are for Noncardiac
More informationAdvances in Joint Replacement
Advances in Joint Replacement Seth Greenky, MD Chairman, Musculoskeletal Services, St. Joseph s Hospital Partner, Syracuse Orthopedic Specialists Associate Clinical Professor, Upstate Medical Center CoMedical
More informationPre-op Clinical Triad - Pulmonary. Sammy Pedram, MD FCCP Assistant Professor of Medicine Pulmonary & Critical Care Medicine March 16, 2018
Pre-op Clinical Triad - Pulmonary Sammy Pedram, MD FCCP Assistant Professor of Medicine Pulmonary & Critical Care Medicine March 16, 2018 Disclosures none Case Mr. G is a 64 year-old man who presents to
More informationPERIOPERATIVE EVALUATION AND ANESTHETIC MANAGEMENT OF PATIENTS WITH CARDIAC DISEASE FOR NON CARDIAC SURGERY
PERIOPERATIVE EVALUATION AND ANESTHETIC MANAGEMENT OF PATIENTS WITH CARDIAC DISEASE FOR NON CARDIAC SURGERY WHICH PATIENT IS AT HIGHEST RISK? 1. 70 yo asymptomatic patient with history of heart failure
More informationEnhanced Recovery After Surgery Getting it Right
Enhanced Recovery After Surgery Getting it Right Aalok Agarwala, M.D., M.B.A. Division Chief, General Surgery Anesthesia Associate Director, Quality and Safety, MGH DACCPM Assistant Professor, Harvard
More informationChallenges in Perioperative Medication Management. Learning Objectives. Case 1. » Appropriate use of beta-blockers. Management of diabetes drugs
Challenges in Perioperative Medication Management Dimitriy Levin, MD Assistant Professor of Medicine University of Colorado Hospital Medicine Group Learning Objectives» Appropriate use of beta-blockers
More informationJohn V. Vanore, DPM Gadsden, AL
Perioperative Considerations John V. Vanore, DPM Gadsden, AL PERIOPERATIVE MANAGEMENT J Foot Ankle Surg 2017:56:336 Goals & Objectives Anticipate & prevent complications Identify difficult or at risk patients
More information2010, Metzler Helfried
Perioperative Strategies in Patients on Dual Antiplatelet Drug Therapy: Noncardiac Surgery H. Metzler Department of Anaesthesiology and Intensive Care Medicine Medical University of Graz, Austria What
More information3/23/2017. Angelika Cyganska, PharmD Austin T. Wilson, MS, PharmD Candidate Europace Oct;14(10): Epub 2012 Aug 24.
Angelika Cyganska, PharmD Austin T. Wilson, MS, PharmD Candidate 2017 Explain the efficacy and safety of triple therapy, in regards to thromboembolic and bleeding risk Summarize the guideline recommendations
More informationDay of Surgery Discharge after Unicompartmental Knee Arthroplasty (UKA): An Effective Perioperative Pathway. Jay Patel, MD Hoag Orthopedic Institute
Day of Surgery Discharge after Unicompartmental Knee Arthroplasty (UKA): An Effective Perioperative Pathway Jay Patel, MD Hoag Orthopedic Institute UKA Rapid Recovery Protocol Purpose of Study Describe
More informationGRAND ROUNDS - DILEMMAS IN ANTICOAGULATION AND ANTIPLATELET THERAPY. Nick Collins February 2017
GRAND ROUNDS - DILEMMAS IN ANTICOAGULATION AND ANTIPLATELET THERAPY Nick Collins February 2017 DISCLOSURES Before I commence Acknowledge.. Interventional Cardiologist Perception evolved. Interventional
More informationPerioperative Medicine 2016 Some Answers, Even More Questions
Learning Objectives Perioperative Medicine 2016 Some Answers, Even More Questions Kurt Pfeifer, MD, FACP, FHM Professor of Medicine Medical College of Wisconsin Outline changes to the ACC/AHA perioperative
More informationAngelika Cyganska, PharmD Austin T. Wilson, MS, PharmD Candidate 2017
Angelika Cyganska, PharmD Austin T. Wilson, MS, PharmD Candidate 2017 Explain the efficacy and safety of triple therapy, in regards to thromboembolic and bleeding risk Summarize the guideline recommendations
More informationt. Recommendations for periprocedural anticoagulation are available lhrough the American College of Chest Physicians Clinical Practice Guidelines.
Name or Policy: Policy Number: 3364-133-116 Department: Approving Officer: Responsible Agent: cope: x Management of Anticoagulation with Invasive Procedures Pharmacy Chief Operating Officer Director of
More informationDesigning Clinical Trials in Perioperative Sleep Medicine
Designing Clinical Trials in Perioperative Sleep Medicine A Rationale and Pragmatic Approach Daniel J. Gottlieb, MD, MPH Director, Sleep Disorders Center, VA Boston Healthcare System Program in Sleep and
More informationAssessment. Consults & Referrals
University of Virginia Health System Clinical Pathway: Whipple Enhanced Recovery After () LOS: 4-5 days Date of Origin/Revision: June 29, 2016/September 6, 2017/January 31, 2018 : SAS : : : D1 D2 D 3/
More informationSlide 1: Perioperative Management of Anticoagulation
Perioperative Management of Anticoagulation by Steven L. Cohn, MD, FACP Director, Medical Consultation Service, Kings County Hospital Center, Clinical Professor of Medicine, SUNY Downstate, Brooklyn, NY
More informationSCORES FOR 4 TH QUARTER, RD QUARTER, 2014
SCORES FOR 4 TH QUARTER, 2013 3 RD QUARTER, 2014 PATIENT SATISFACTION SCORES (HCAHPS): 4 STARS OUT OF 5 (ONLY 4 AREA ACUTE CARE HOSPITALS RECEIVED A 4-STAR RATING. NONE ACHIEVED 5-STARS). STRUCTURAL MEASURES:
More informationHEART OF THE MATTER: cardiac issues in safe endoscopy & sedation
HEART OF THE MATTER: cardiac issues in safe endoscopy & sedation YUVAL KONSTANTINO M.D. CARDIOLOGY DEPARTMENT, ELECTROPHYSIOLOGY UNIT, SOROKA MEDICAL CENTER, BEN-GURION UNIVERSITY OUTLINE 1 2 3 Anticoagulation
More informationClinical Controversies in Perioperative Medicine
Update on Perioperative Medicine Clinical Controversies in Perioperative Medicine Hugo Quinny Cheng, MD Division of Hospital Medicine University of California, San Francisco Cardiac Medications & Perioperative
More informationPerioperative Medicine 2017 November 3, Disclosures
Perioperative Medicine 2017 November 3, 2017 Scott Marsal, MD MSc FACP Chief, Medicine Division Medical Director, Quality & Patient Safety Providence St. Vincent Medical Center Disclosures No conflicts
More informationPerioperative Care of Older Adults
Perioperative Care of Older Adults SARAH A. WINGFIELD, MD AND THOMAS O. DALTON, MD UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER DIVISION OF GERIATRIC MEDICINE We have no disclosures. Objectives -Recognize
More informationPerioperative Care of Older Adults
Perioperative Care of Older Adults SARAH A. WINGFIELD, MD AND THOMAS O. DALTON, MD UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER DIVISION OF GERIATRIC MEDICINE We have no disclosures. Objectives -Recognize
More informationIndividual Therapeutic Selection Of Anti-coagulants And Periprocedural. Miguel Valderrábano, MD
Individual Therapeutic Selection Of Anti-coagulants And Periprocedural Management Miguel Valderrábano, MD Outline Does the patient need anticoagulation? Review of clinical evidence for each anticoagulant
More informationThe Challenge. Warfarin or Novel Oral Anti-Coagulants in the PCI patient? Anticoagulation/Stroke
Anticoagulation/Stroke Warfarin v new oral anticoagulants post PCI Warfarin or Novel Oral Anti-Coagulants in the PCI patient? Gerry Devlin Chairs: Phillip Matsis & Tony Scott Gerry Devlin Honorary Associate
More informationClinical Controversies in Perioperative Medicine!
Clinical Controversies in Perioperative Medicine! Hugo Quinny Cheng, MD! Division of Hospital Medicine! University of California, San Francisco! Disclosures! Perioperative beta-blockade & statin therapy
More informationPreoperative Management of Patients Receiving Antithrombotics
Preoperative Management of Patients Receiving Antithrombotics Bleeding complications remain an important concern for most surgical procedures. Attempts to minimize the risk of these complications by removing
More informationAtrial fibrillation and anticoagulation JIR-PING BOEY, DEPARTMENT OF HAEMATOLOGY, FLINDERS MEDICAL CENTRE FEBRUARY 2016
1 Atrial fibrillation and anticoagulation JIR-PING BOEY, DEPARTMENT OF HAEMATOLOGY, FLINDERS MEDICAL CENTRE FEBRUARY 2016 Disclosures 2 No conflicts of interest Some questions 3 Should my patient with
More informationDisclosures. Total knee and Total Hip Replacement, a Fast Track. Outline of my talk. What is Fast Track Arthroplasty? I have nothing to disclose
Total knee and Total Hip Replacement, a Fast Track Muhammad I Shaikh M.D.,Ph.D. Associate Professor of Anesthesiology, UCSF Outline of my talk Definition of Fast Track Principles of FT as applied to Orthopedics
More informationPain Management Protocol in Adolescent Idiopathic Spinal Fusion Reduces Length of Stay and Complications
Pain Management Protocol in Adolescent Idiopathic Spinal Fusion Reduces Length of Stay and Complications Abstract Authors: Karen Martin, RHIT, CPHQ - Surgical Clinical Reviewer - Quality Management Analyst,
More informationDOAC and NOAC are terms for a novel class of directly acting oral anticoagulant drugs including Rivaroxaban, Apixaban, Edoxaban, and Dabigatran.
Guideline for Patients on Direct Oral Anticoagulant Therapy Requiring Urgent Surgery for Hip Fracture Trust Ref:C10/2017 1. Introduction This guideline is for the clinical management of patients on direct
More informationPreoperative Evaluation Guidelines and Work up
Preoperative Evaluation Guidelines and Work up Wesley Fiser, MD Disclosures: None 1 Case An 80 year old woman with osteoarthritis of the hip, DM, CKD (Cr 2.1), and HTN is diagnosed with an obstructing
More informationPrescribe appropriate immunizations for. Prescribe childhood immunization as per. Prescribe influenza vaccinations in high-risk
Supplemental Digital Appendix 1 46 Health Care Problems and the Corresponding 59 Practice Indicators Expected of All Physicians Entering or in Practice Infectious and parasitic diseases Avoidable complications/death
More informationIndications of Anticoagulants; Which Agent to Use for Your Patient? Marc Carrier MD MSc FRCPC Thrombosis Program Ottawa Hospital Research Institute
Indications of Anticoagulants; Which Agent to Use for Your Patient? Marc Carrier MD MSc FRCPC Thrombosis Program Ottawa Hospital Research Institute Disclosures Research Support/P.I. Employee Leo Pharma
More informationEnhanced Recovery Thoracic Surgery. Esophagus Pathway
Enhanced Recovery Thoracic Surgery Esophagus Pathway Preoperative Patient Education/Expectations for Hospital and Home Medical Risk Consultation: Cardiac Clearance and PFTs for All Patients Surgery Wellness
More informationFluid Balance in an Enhanced Recovery Pathway. Edwin Itenberg, DO, FACS, FASCRS St. Joseph Mercy Oakland MSQC/ASPIRE Meeting April 28, 2017
Fluid Balance in an Enhanced Recovery Pathway Edwin Itenberg, DO, FACS, FASCRS St. Joseph Mercy Oakland MSQC/ASPIRE Meeting April 28, 2017 No Disclosures 2 Introduction The optimal intravenous fluid regimen
More informationObjectives. Preoperative Assessment of the Geriatric Patient
Preoperative Assessment of the Geriatric Patient Kelsey Walker, MD Geriatric Grand Rounds May 21, 2015 Objectives Introduction: why does it matter? Review traditional tools to assess preoperative risk:
More informationWhich Patients are Too High Risk for Ambulatory Surgery?
Which Patients are Too High Risk for Ambulatory Surgery? BobbieJean Sweitzer, M.D. Director, Anesthesia Perioperative Medicine Clinic Professor of Anesthesia and Critical Care Professor of Medicine University
More informationDual antiplatelet therapy (DAPT) in the era of Novel Oral Anticoagulants (NOACs) SACIS 2015
Dual antiplatelet therapy (DAPT) in the era of Novel Oral Anticoagulants (NOACs) SACIS 2015 Wesam A Alhejily MD FRCPC FACP FACC FSCAI Assistant Professor of Medicine Chief Of Adult Cardiology Consultant
More informationLumbar Fusion. Reference Guide for PACU CLINICAL PATHWAY. All patient variances to the pathway are to be circled and addressed in the progress notes.
Reference Guide for PACU Lumbar Fusion CLINICAL PATHWAY All patient variances to the pathway are to be circled and addressed in the progress notes. This Clinical Pathway is intended to assist in clinical
More informationPRE-OP H&P S: WHAT REALLY MATTERS
1 2 PRE-OP H&P S: WHAT REALLY MATTERS Jenikka Soyring, DNP Why Pre-op Assessments Reduce risk for cardiac, pulmonary and infectious complications Not meant to clear for surgery It is to evaluate and implement
More informationNew York City Development of the Geriatric Collaborative
New York City - 2014 Development of the Geriatric Collaborative The Clinical Problem More than 50% persons age 65 years will have some surgical procedure in the remainder of his or her lifetime Outcome
More informationSleep Apnea and ifficulty in Extubation. Jean Louis BOURGAIN May 15, 2016
Sleep Apnea and ifficulty in Extubation Jean Louis BOURGAIN May 15, 2016 Introduction Repetitive collapse of the upper airway > sleep fragmentation, > hypoxemia, hypercapnia, > marked variations in intrathoracic
More informationAntiplatelet and Anti-Thrombotic Therapy. Ivan Anderson, MD RIHVH Cardiology
Antiplatelet and Anti-Thrombotic Therapy Ivan Anderson, MD RIHVH Cardiology Outline Anti-thrombotic therapy Risk stratification of stroke with atrial fibrillation DVT and PE treatment Pharmacology Anti-platelet
More informationAMI Talking Points. Provide appropriate treatment to Acute MI patients with these core measures:
AMI Provide appropriate treatment to Acute MI patients with these core measures: Aspirin received within 24 hours of arrival or contraindication documented Primary PCI Received Within 90 Minutes of Hospital
More informationManagement of Hip Fractures
Management of Hip Fractures in the Elderly Patient David A. Brown MD COL U.S. Army Ret. The Center for Orthopedics and Neurosurgery Optimizing Management of Hip Fractures in the Elderly Patient Optimizing
More informationDr Alireza Yarahmadi and Dr Arvind Perathur Mercy Medical Center - Winter Retreat Des Moines February 2012
Dr Alireza Yarahmadi and Dr Arvind Perathur Mercy Medical Center - Winter Retreat Des Moines February 2012 Why screen of OSA prior to surgery? What factors increase the risk? When due to anticipate problems?
More informationTools for Optimal Preoperative Preparation Strong for Surgery. Thomas K. Varghese Jr. MD, MS,
Tools for Optimal Preoperative Preparation Strong for Surgery Thomas K. Varghese Jr. MD, MS, FACS @tomvarghesejr None Disclosures Achieving Quality and Safety in the Five Phases of Care Preoperative and
More informationNerve Blocks & Long Acting Analgesia for Plastic Surgeons. Karol A Gutowski, MD, FACS
Nerve Blocks & Long Acting Analgesia for Plastic Surgeons Karol A Gutowski, MD, FACS Disclosures None related to this topic Why is Non-Opioid Analgesia Important Opioid epidemic Less opioid use Less PONV
More informationUpdate in Perioperative Anticoagulation and Antiplatelet management
Update in Perioperative Anticoagulation and Antiplatelet management Grand Rounds October 31, 2014 Brooke Hall, MD Steve Kornfeld, MD Bruce McLellan, MD Nothing to disclose Objectives Describe the updates
More informationSurgical Care, Pneumonia, Immunizations and Emergency Department Core Measures
Surgical Care, Pneumonia, Immunizations and Emergency Department Core Measures Audrey Paulman, MD, MMM Principal Clinical Coordinator & Jackie Trojan, RN, BSN Quality Improvement Advisor This material
More informationTiming of Surgery After Percutaneous Coronary Intervention
Timing of Surgery After Percutaneous Coronary Intervention Deepak Talreja, MD, FACC Bayview/EVMS/Sentara Outline/Highlights Timing of elective surgery What to do with medications Stopping anti-platelet
More informationIntro Who should read this document 2 Key practice points 2 What is new in this version 3 Background 3 Guideline Subsection headings
Enhanced Recovery for Major Urology and Gynaecological Classification: Clinical Guideline Lead Author: Dr Dominic O Connor Additional author(s): Jane Kingham Authors Division: Anaesthesia Unique ID: DDCAna3(12)
More informationPreoperative Risk. Geoffrey C Zarrella DO FACC. Assessment
Preoperative Risk Geoffrey C Zarrella DO FACC Assessment your late add ons keep calm use your tools stick to your guns PURPOSE OF THE PREOP EVAL ASSESS PERIOP RISK CAN INFORM DECISION TO PROCEED OR
More informationPerioperative pathophysiology and the objectives behind Enhanced Recovery Care
Perioperative pathophysiology and the objectives behind Enhanced Recovery Care Francesco Carli, MD, MPhil McGill University Montreal, Canada franco.carli@mcgill.ca 60 patients (74 yo) Open colon resection
More informationWhat s new with DOACs? Defining place in therapy for edoxaban &
What s new with DOACs? Defining place in therapy for edoxaban & Use of DOACs in cardioversion Caitlin M. Gibson, PharmD, BCPS Assistant Professor, Department of Pharmacotherapy University of North Texas
More information